Sydney Retina Clinic

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Diabetic eye disease3 trials
• Macular degeneration2 trials

Phase

• Phase 22 trials
• Phase 32 trials
• Phase 2/31 trial

Status

• Completed3 trials
• Active, not recruiting2 trials

Lead sponsor

• Astellas Pharma Global Development, Inc.1 trial
• Bayer1 trial
• EyeBiotech Ltd.1 trial
• Ripple Therapeutics Pty Ltd1 trial
• Vantage Biosciences Ltd1 trial

Running trials

• Active, not recruiting

  A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01

  NCT06770933· Phase 2· Vantage Biosciences Ltd· Source

• Active, not recruiting

  A Study to Evaluate the Efficacy and Safety of 2 Doses of Remigromig (EYE103) Compared With Ranibizumab (0.5 mg) in Participants With DME

  NCT06571045· Phase 2/3· EyeBiotech Ltd.· Source

Closed trials

• Completed

  Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy

  NCT05536297· Phase 3· Astellas Pharma Global Development, Inc.· Source

• Completed

  Safety and Efficacy of IBE-814 Intravitreal (IVT) Implant - a Sustained, Low Dose Dexamethasone Therapy

  NCT04576689· Phase 2· Ripple Therapeutics Pty Ltd· Source

• Completed

  Study of the Effects of High Dose Aflibercept Injected Into the Eye of Patients With an Age-related Disorder That Causes Loss of Vision Due to Growth of Abnormal Blood Vessels at the Back of the Eye

  NCT04423718· Phase 3· Bayer· Source